Opportunities And Challenges In The UK’s Medical Cannabis Market

Seeing Significant Growth

The medical cannabis market in the UK has seen significant growth in recent years. Due to this, the UK has been dubbed the primary driver of Europe’s new growth in the region’s medical cannabis market. By the end of the year 2024, it has been forecasted that about €240 million (£205 million) will have been made in sales of medical cannabis from over 62, 960 patients. With this number, each patient on average would spend about  € 3,811 worth (£3,261) on medical cannabis per year, or € 318 worth (£272) per month. These numbers dwarf what is obtainable in Germany which has the largest number of cannabis consumers in Europe.

From what has been observed, this growth of the medical cannabis market in the UK is driven primarily by increasing patient demand and evolving positive regulatory frameworks. However, alongside these opportunities, there are several stiff challenges that both patients and UK healthcare professionals still face. Thus this article will explore the potential of the UK’s medical cannabis market, particularly in the context of conditions like ADHD, while also addressing the hurdles that come with this emerging sector…

Opportunities in the UK’s Medical Cannabis Market

Below are some of the numerous opportunities inherent in the UK medical cannabis market for the consumers, suppliers and community at large.

Increasing Patient Demand

The demand for any product is what drives its continued supply to the market. As the public awareness of the potential health benefits of medical cannabis in the UK increases, more patients will demand the product leading to an increase in its supply (all things being equal). This new demand is often created by UK patients seeking alternative treatment to ADHD conditions cannabis strains for ADHD can offer relief.

Expanding Research and Clinical Trials on Medical Cannabis

While anecdotal reports from patients are promising, scientific evidence is still limited, highlighting the need for further research. With the growing number of medical cannabis consumers all over the world, there is a wealth of data leveraged in the UK for further research on the potency of medical cannabis in managing health conditions related to ADHD. These researchers are already looking into which strains of cannabis are more effective than the other in managing specific health concerns.

Regulatory Support and Professional Education

Hardly will anything work in the UK without some sort of government approval and/or support. The medical cannabis industry in the UK has seen a lot of positive regulatory adjustments such as the government’s support of research institutes, continuous training of professionals and easing access to medical cannabis by allowing bulk, non-patient-specific, importation. The latter was implemented in March 2020 and it has so far improved the timely delivery of the product to patients and reduction of the purchase cost.

Market Challenges for Medical Cannabis Usage in the UK

Despite the gains already made in the market for medical cannabis usage in the UK, some significant challenges persist as a cog in its wheel of progress. They include the following:

Stigma and Public Perception

Despite the increasing acceptance of medical cannabis for health management purposes, some level of stigma for cannabis users still exists in certain quarters among the populace. This in turn discourages some patients from trying out the product in the alleviation of their ailment to avoid being judged or misunderstood. However, by providing clear, accurate, and empathetic information, on medical cannabis the way Releaf UK does, the clinic aims to help patients feel more comfortable discussing their treatment options with their healthcare providers.

Access and Affordability of the Product

For some patients who do not have access to private insurance or may need a particular strain of cannabis, the cost of purchasing the product may be a bit prohibitive. Thus, this will make it difficult for such patients to get the much-needed beneficial treatment for their condition. With this, there is a dire need to make different strains of the product available and affordable for the populace across all income groups.

Regulatory and Legal Framework

Though the current UK government’s regulatory guidelines on medical cannabis have already been cited in a positive light as instrumental to the growth of the cannabis market, there still exist a lot of constraints. These include complex prescription processes, stringent regulations that can make it difficult for patients to obtain the treatments they need, etc. For example, while some people can have ready access to cannabis for cooking purposes, patients who need it to alleviate their ADHD health conditions may be subjected to complex prescription procedures before they get their hands on the product.

Outlook of The Current Medical Cannabis Landscape in the UK

It was not too long ago in the year 2018, precisely on the 1st of November that the first medical cannabis prescription in the UK was given out. Thus the UK’s medical cannabis market is still relatively young but has made giant strides. Patients seek medical cannabis for various medical conditions, including chronic pain, multiple sclerosis, epilepsy, and anxiety. Cannabis has been effective in the treatment and management of these conditions because it contains cannabinoids, like THC (tetrahydrocannabinol) and CBD (cannabidiol). These cannabinoids typically interact with the endocannabinoid system in the human body. The endocannabinoid system plays a role in regulating pain, mood, and other human body functions.

There has been a growing interest in the use of medical cannabis for ADHD (Attention Deficit Hyperactivity Disorder) management. For a long time now, ADHD which is a chronic development disorder often characterized by persistent symptoms of inattention, impulsivity and hyperactivity has been treated medically with drugs like Ritalin or Adderall. Some UK patients and healthcare experts are increasingly exploring the management of ADHD with medical cannabis as a complementary or alternative therapy. In the years to come, a lot of research would have been documented and published in this regard with the likes of renowned UK cannabis clinic Releaf – Removing the Stigma from Medical Cannabis – leading the way.